care
patient
sever
pneumonia
intens
care
unit
icu
routin
face
frustrat
challeng
familiar
clinician
treat
infect
caus
pathogen
use
right
antibiot
sputum
cultur
result
ever
come
back
pathogen
identifi
patient
get
better
actual
rule
infect
patient
go
recov
critic
question
frequent
answer
bedsid
root
caus
problem
stem
relianc
culturebas
diagnost
test
neither
sensit
fast
enough
guid
precis
time
treatment
result
empir
suboptim
care
individu
patient
substanti
diagnost
limit
surpris
sever
pneumonia
high
mortal
rate
longterm
morbid
icu
survivor
patient
present
fever
sputum
purul
hypoxia
abnorm
chest
radiograph
infecti
bacteri
pneumonia
rightli
top
differenti
diagnosi
along
collect
microbiolog
cultur
specimen
respiratori
secret
andor
blood
sampl
prompt
initi
empir
antibiot
imper
even
small
delay
translat
measur
increas
mortal
follow
initi
encount
clinic
syndrom
recognit
respons
precis
identif
culprit
pathogen
antimicrobi
suscept
need
tailor
therapi
howev
cultur
requir
long
incub
period
h
provid
action
result
frequent
fail
defin
caus
organ
case
despit
systemat
workup
offer
specif
guidanc
clinician
fig
result
untailor
broadspectrum
antibiot
typic
target
grampositiveneg
atyp
bacteria
disproportion
intens
inadequ
entir
unnecessari
depend
caus
microbi
agent
intens
regimen
also
increas
risk
toxic
ablat
indigen
protect
microbiota
lead
secondari
infect
clostridium
difficil
coliti
concern
appli
select
pressur
emerg
multiresist
microbi
strain
major
public
health
threat
thu
abil
effici
precis
target
antibiot
unmet
critic
need
care
sever
pneumonia
icu
fuel
interest
leverag
lung
microbiom
studi
tool
purpos
recent
wave
human
lung
microbiom
research
made
possibl
develop
nextgener
sequenc
ng
techniqu
without
need
ex
vivo
growth
isol
microbi
speci
ampliconbas
sequenc
highli
conserv
rrna
gene
sequenc
bacteria
uncov
bacteri
commun
respiratori
health
diseas
low
biomass
complex
composit
debunk
longheld
dogma
lung
steril
proofofconcept
examin
valid
sequenc
diagnost
tool
pneumonia
group
other
demonstr
respiratori
sampl
intub
patient
pneumonia
profil
low
alpha
divers
domin
taxa
correspond
clinic
signific
pathogen
organ
isol
cultur
staphylococcu
aureu
klebsiella
pneumonia
sequenc
also
afford
us
firsttim
survey
composit
diagnost
black
box
cultureneg
case
repres
cohort
commun
domin
common
pathogen
yet
miss
cultur
remain
major
case
show
high
abund
bacteria
probabl
oral
origin
eg
prevotella
veillonella
etc
challeng
convent
think
pneumonia
pathogenesi
presumpt
clinic
diagnosi
despit
novel
insight
ecolog
pneumonia
sequenc
deploy
quickli
enough
clinic
applic
provid
inform
bacteri
speciesstrain
antibiot
resist
nonbacteri
pathogen
overcom
limit
sequenc
whole
metacommun
shotgun
sequenc
dna
metagenom
rna
metatranscriptom
begun
appli
respiratori
sampl
captur
wide
microorganism
breadth
code
potenti
pathogen
metagenom
function
activ
commun
metatranscriptom
advent
rapid
pointofcar
poc
sequenc
devic
nanopor
sequenc
oxford
nanopor
technolog
bedsid
pathogen
identif
antibiot
resist
predict
may
becom
feasibl
matter
hour
proofofconcept
case
report
investig
use
nanopor
sequenc
compet
clinic
microbiolog
lab
determin
defin
caus
pathogen
first
inde
detect
pathogen
sequenc
sever
hour
cultur
provid
diagnost
signal
apart
potenti
faster
diagnosi
shotgun
approach
offer
unpreced
opportun
hypothesisfre
diagnost
agnost
interrog
metacommun
member
includ
virus
fungi
parasit
metagenomicstranscriptom
expand
knowledg
pathogen
organ
character
poorli
defin
clinic
syndrom
help
identifi
emerg
diseas
entiti
across
spectrum
human
patholog
howev
shotgun
approach
yet
optim
applic
respiratori
sampl
overwhelm
amount
human
dna
compar
microbi
dna
ratio
compromis
signal
analys
shotgun
approach
readi
clinic
prime
time
due
technic
challeng
also
still
lack
diagnost
test
framework
util
output
feed
sequenc
report
clinician
without
obligatori
yet
develop
interpret
decis
support
would
stir
confus
clinic
inappropri
decis
make
clinic
investig
look
futur
research
need
type
clinic
studi
allow
us
develop
action
diagnost
test
primari
focu
metagenom
diagnosi
bacteri
pneumonia
mandat
target
antibiot
therapi
creat
clinic
use
diagnost
test
base
metagenom
need
overcom
sever
technolog
practic
costrel
challeng
includ
limit
sampl
prepar
optim
minim
handson
time
sequenc
error
reduct
streamlin
analyt
pipelin
wherea
task
trivial
expect
align
academ
industri
interest
field
technic
capac
rapid
sequenc
devic
continu
evolv
measur
improv
fidel
resolut
timeli
costeffect
within
next
year
advanc
hold
potenti
chang
diagnost
paradigm
pulmonari
infect
also
sever
infecti
diseas
culturebas
diagnost
approach
current
use
nonetheless
clinic
translat
standpoint
question
remain
move
sequenc
output
clinic
action
test
result
formid
challeng
uniqu
critic
care
pulmonari
infect
diagnost
perform
absenc
gold
standard
rather
presenc
standard
care
golden
metagenom
sequenc
directli
patient
sampl
comprehens
detect
viabl
dead
fastidi
bacteria
wherea
clinic
microbiolog
cultur
effect
grow
subset
cultiv
bacteria
inhibit
kill
anteced
antibiot
administr
given
metagenom
far
sensit
technolog
convent
sensitivityspecif
analys
contrast
metagenom
cultur
meaningless
fig
time
ultrasensit
metagenom
creat
report
problem
detect
commens
commun
bacteria
typic
consid
pathogen
requir
contextspecif
interpret
pathogen
lack
thereof
overcom
diagnost
framework
challeng
ought
appli
advanc
method
assess
clinic
valid
util
answer
clinic
valid
question
main
prerequisit
knowledg
true
pathogen
pneumonia
unavail
case
despit
systemat
workup
thu
analys
split
known
answer
versu
unknown
answer
pathogenconfirm
case
cultur
rare
ancillari
antigenicantibodi
test
allow
direct
comparison
deriv
diagnost
threshold
sequenc
output
eg
number
specif
pathogen
read
commun
divers
indic
associ
bacteri
cultur
posit
clinic
accept
threshold
eg
cfu
cultureposit
case
also
offer
opportun
refin
predict
algorithm
antibiot
resist
gene
detect
versu
clinic
antibiogram
realtim
antibiot
recommend
would
becom
feasibl
consequ
observ
studi
cultureconfirm
case
help
develop
statist
model
andor
train
machinelearn
algorithm
sequencingbas
definit
pneumonia
pneumonia
index
cultureneg
case
true
pathogen
unknown
diagnosi
syndrom
base
clinic
constel
interpret
metagenom
bacteri
signal
case
need
refin
clinic
refer
standard
synthesi
multilevel
data
data
includ
clinic
variabl
eg
vital
sign
leukocytosi
sputum
purul
chest
radiographi
score
valid
biomark
host
inflamm
eg
alveolar
epitheli
injuri
receptor
advanc
glycat
product
rage
infecti
respons
procalcitonin
combin
construct
gold
standard
pneumonia
definit
definit
emerg
either
supervis
learn
involv
expert
input
clearcut
case
two
end
pneumonia
diagnosi
distribut
unsupervis
classif
method
identifi
phenotyp
class
directli
metagenom
clinic
data
iter
train
metagenom
profil
translat
probabl
pneumonia
diagnosi
also
incorpor
prior
probabl
learn
refer
cultureposit
profil
end
complex
algorithm
output
simpl
binari
order
clinic
usabl
pneumonia
pathogen
x
pneumonia
fig
demonstr
clinic
efficaci
improv
patient
outcom
ultim
determin
clinic
adopt
diagnost
test
regardless
sophist
idea
genet
exception
ie
belief
genet
inform
uniqu
import
diseas
predict
clinic
avail
inform
prove
conduc
clinic
translat
genom
similarli
microbiomebas
approach
reach
standard
threshold
scientif
evid
rigor
recommend
use
thu
metagenomicsbas
diagnost
test
compar
standardofcar
microbiolog
cultur
random
clinic
trial
anticip
improv
diagnost
accuraci
sequenc
would
cut
empir
unnecessari
antibiot
result
improv
least
noninferior
clinic
respons
outcom
advent
ng
microbiom
scientif
field
offer
revolution
opportun
enter
new
cultureindepend
epoch
clinic
think
definit
manag
infecti
diseas
ongo
technolog
bioinformat
innov
coupl
smart
clinic
test
sophist
comput
biolog
analyt
hope
bring
bedsid
nextgener
diagnost
tool
time
target
precis
antibiot
use
icu
despit
challeng
way
cultureindepend
era
rubicon
cross
